Osamah Barasheed, Nedal Almasri, Al-Mamoon Badahdah, Leon Heron, Janette Taylor, Kenneth McPhee, Iman Ridda, Elizabeth Haworth, Dominic E Dwyer, Harunor Rashid and Robert Booy on behalf of the Hajj Research Team
Mohamed Tashani, Osamah Barasheed, Mohammad Azeem, Mohammad Alfelali, Al-Mamoon Badahdah, Hamid Bokhary, Nedal Almasri, Jassir Alshehri, Ghassan Matbouly, Nadeen Kalantan, Leon Heron, Iman Ridda, Elizabeth Haworth, Atif Asghar, Harunor Rashid and Robert Booy on behalf of the Hajj Research Team
Mohammad Alfelali, Osamah Barasheed, Jassir Alshehri, Hamid Bokhary, Sami Alsaedi, Abdulrahman Alhamzi, Naji Aljohani, Tim Driscoll and Harunor Rashid on behalf of the Diabetic Foot Care Research Team in Hajj
Jean-Marc Sabatier Laboratoire ERT 62 'Ingénierie des peptides à visée thérapeutique' Université de la Méditerranée Faculté de Médecine Nord Boulevard Pierre Dramard 13916 - MARSEILLE, Cedex 20 (France)
Jean-Marc SABATIER is a Director of research at the French CNRS, with PhD and HDR degrees in Biochemistry and Microbiology. He headed several academic research teams (CNRS, INSERM and University), as well as a combined academic-industry research laboratory devoted to the engineering of therapeutic peptides (ERT62, Marseilles, France). He was also a Director of Research for several French private companies as well as a Canadian public company. He acts as a Consultant for top pharmaceutical and cosmetic companies. Dr. Sabatier works in the field of animal toxins. He so far contributed to several books in toxinology and virology, and more than 160 scientific articles, 180 communications, and 53 patents in both biology and chemistry.